JP2022554330A5 - - Google Patents

Info

Publication number
JP2022554330A5
JP2022554330A5 JP2022525588A JP2022525588A JP2022554330A5 JP 2022554330 A5 JP2022554330 A5 JP 2022554330A5 JP 2022525588 A JP2022525588 A JP 2022525588A JP 2022525588 A JP2022525588 A JP 2022525588A JP 2022554330 A5 JP2022554330 A5 JP 2022554330A5
Authority
JP
Japan
Application number
JP2022525588A
Other languages
Japanese (ja)
Other versions
JP2022554330A (ja
JP7703272B2 (ja
JPWO2021083209A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2020/124381 external-priority patent/WO2021083209A1/en
Publication of JP2022554330A publication Critical patent/JP2022554330A/ja
Publication of JPWO2021083209A5 publication Critical patent/JPWO2021083209A5/ja
Publication of JP2022554330A5 publication Critical patent/JP2022554330A5/ja
Application granted granted Critical
Publication of JP7703272B2 publication Critical patent/JP7703272B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022525588A 2019-10-29 2020-10-28 Ssao阻害剤およびその使用 Active JP7703272B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN2019113957 2019-10-29
CNPCT/CN2019/113957 2019-10-29
CN2020087022 2020-04-26
CNPCT/CN2020/087022 2020-04-26
PCT/CN2020/124381 WO2021083209A1 (en) 2019-10-29 2020-10-28 Ssao inhibitors and use thereof

Publications (4)

Publication Number Publication Date
JP2022554330A JP2022554330A (ja) 2022-12-28
JPWO2021083209A5 JPWO2021083209A5 (https=) 2023-11-06
JP2022554330A5 true JP2022554330A5 (https=) 2023-11-06
JP7703272B2 JP7703272B2 (ja) 2025-07-07

Family

ID=75714874

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022525588A Active JP7703272B2 (ja) 2019-10-29 2020-10-28 Ssao阻害剤およびその使用

Country Status (11)

Country Link
US (3) US11472769B2 (https=)
EP (1) EP4051669A4 (https=)
JP (1) JP7703272B2 (https=)
KR (1) KR20220090553A (https=)
CN (1) CN114901649B (https=)
AU (1) AU2020377093B2 (https=)
BR (1) BR112022007974A2 (https=)
CA (1) CA3155114A1 (https=)
IL (1) IL292416B2 (https=)
MX (1) MX2022005199A (https=)
WO (1) WO2021083209A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2022005199A (es) 2019-10-29 2022-08-04 Eccogene Shanghai Co Ltd Inhibidores de ssao y uso de los mismos.
CN117624080A (zh) * 2023-11-30 2024-03-01 绍兴上虞新银邦生化有限公司 一种丙硫菌唑中间体的合成方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007120528A2 (en) 2006-03-31 2007-10-25 La Jolla Pharmaceutical Company Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment and prevention of diseases
JP2011504485A (ja) 2007-11-21 2011-02-10 ファーマクシス リミテッド Ssao/vap−1のハロアリルアミン阻害剤およびその用途
SG193307A1 (en) 2011-03-15 2013-10-30 Astellas Pharma Inc Guanidine compound
EP3438087A1 (en) 2012-05-02 2019-02-06 Boehringer Ingelheim International GmbH Substituted 3-haloallylamine inhibitors of ssao and uses thereof
US10759781B2 (en) 2015-08-06 2020-09-01 Ube Industries, Ltd. Substituted guanidine derivatives
EP3423436B1 (en) 2016-03-03 2020-09-16 Boehringer Ingelheim International GmbH Pyridinylmethyl carbamimidoylcarbamate derivatives and their use as aoc3 inhibitors
EP3423434B1 (en) 2016-03-03 2020-01-15 Boehringer Ingelheim International GmbH 4-cyano-benzyl carbamimidoylcarbamate derivatives and their use as aoc3 inhibitors
ES2844926T3 (es) 2016-05-12 2021-07-23 Boehringer Ingelheim Int Derivados de piridinilo, composiciones farmacéuticas y usos de los mismos como inhibidores de AOC3
WO2018027892A1 (en) 2016-08-12 2018-02-15 Eli Lilly And Company Amino pyrimidine ssao inhibitors
BR112019005930A2 (pt) 2016-10-19 2019-06-11 Boehringer Ingelheim Int combinações compreendendo um inibidor de ssao/vap-1 e um inibidor de sglt2, e usos das mesmas
WO2018148856A1 (en) 2017-02-14 2018-08-23 Eli Lilly And Company Diazaspirodecanyl-pyrimidine compounds useful as ssao inhibitors
US20200087248A1 (en) 2017-04-28 2020-03-19 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Fluoroallylamine Derivative And Use Thereof
AU2018287777B2 (en) 2017-06-20 2020-05-21 Shandong Danhong Pharmaceutical Co., Ltd. SSAO inhibitor
CN109251166B (zh) 2017-07-13 2021-11-05 广东东阳光药业有限公司 抑制ssao/vap-1的胺类化合物及其在医药上的应用
WO2019024924A1 (zh) * 2017-08-04 2019-02-07 广东东阳光药业有限公司 抑制ssao/vap-1的胺类化合物及其在医药上的应用
CN109810041B (zh) 2017-11-21 2023-08-15 药捷安康(南京)科技股份有限公司 卤代烯丙基胺类ssao/vap-1抑制剂及其应用
CN108047213A (zh) 2017-12-22 2018-05-18 佛山汉方中医医院有限公司 一种含硫环的氟噻吩的二环腈类化合物及其用途
CN108003166A (zh) 2017-12-23 2018-05-08 广东赛博科技有限公司 含哌嗪基和哌嗪三唑类结构化合物、制备方法及其用途
CN107935993A (zh) 2017-12-29 2018-04-20 佛山汉方中医医院有限公司 甲基金刚烷和硝基吡啶结构衍生物、其制备方法及其用途
WO2019241751A1 (en) * 2018-06-15 2019-12-19 Metacrine, Inc. Ssao inhibitors and uses thereof
AU2019365213A1 (en) * 2018-10-24 2021-06-03 Metacrine, Inc. SSAO inhibitors and uses thereof
MX2022005199A (es) 2019-10-29 2022-08-04 Eccogene Shanghai Co Ltd Inhibidores de ssao y uso de los mismos.

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
JP2022554330A5 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011610A2 (https=)
BR112023011539A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)